Studies on the bioactive-guided tissue regeneration membrane.
Guided tissue regeneration (GTR) is a clinical procedure promoting regeneration of periodontal tissues. In general, this technique provides spaces for periodontal cells to repopulate and regenerate in the periodontal defect by physically preventing an invasion of gingival tissues in the affected area. Although various reports certify clinical success of GTR, high variation of favourable outcome among studies leads to the investigation to improve clinical GTR efficiency for periodontal tissue regeneration. Recent development of GTR membrane aims to augment bioactivity for facilitating and enhancing tissue healing and regeneration. Various approaches are examined, for example, the release of growth factor, the incorporation of bioactive ceramics and the delivery of antimicrobial agents. Polycaprolactone (PCL) is widely used in biomedical application due to its acceptable biocompatibility and degradability. Physical characteristics are easy to manipulate. Various forms and shapes are simple to fabricate. PCL can be employed as GTR membrane and scaffold filling in the periodontal-defect area. Bioactive PCL could be fabricated by various techniques to enhance periodontal tissue regeneration. The present chapter reviews the bioactive approaches for GTR membrane, and the potential utilization of PCL for GTR application is described.
- guided tissue regeneration
- periodontal tissues
The guided tissue regeneration (GTR) aims to regenerate the periodontal tissue apparatus in its original architecture. GTR procedure is well established and has proven to be a successful clinical procedure to regenerate periodontal tissues . Treatment is conducted by applying a membrane barrier over the affected area in order to exclude the gingival tissues, connective tissues and epithelial tissues from the defect area, allowing specific cells to regenerate in the affected site . Various materials have been employed and investigated in both clinical and experimental setting . However, the results from systemic review and meta-analysis demonstrated that guided tissue regeneration technique exhibited highly variable between and within the studies [3, 4]. In human, the weighted-average bone-filling ration in the infrabony defect treated by GTR alone ranges from 42 to 77%, implying the variety of response . One possibility of this discrepancy is the different types of membrane employed in the studies . Thus, it suggests that the clinical available membranes are still needed for further improvement to efficiently promote periodontal tissue regeneration.
In order to advance the healing capability of the periodontal tissues, the membrane modification is widely investigated. In this regard, the development of drug/bioactive agent-containing membrane has been developed. Various specific agents, such as bioactive ceramics, antimicrobials, growth factors and small molecules, have been added into the membrane aiming to facilitate and/or enhance periodontal tissue regeneration [2, 6]. Many studies have proven the incremental effect imposed by the combination of these agents with traditional guided tissue regeneration membranes .
Polycaprolactone (PCL) has been introduced as a candidate biomaterial for tissue regeneration. It has many properties that satisfied the criterion for GTR membrane. For example, it exhibits biocompatibility properties and is not toxic . It has been widely investigated as a scaffold material for tissue-engineering application [8, 9]. In addition, it has been approved for clinical application, for example, suture materials, confirming the biocompatibility and safety in clinical use. Besides, the physical characteristics (e.g. strength and degradability) could be easily manipulated. Further, a precise control of membrane architecture could be simply fabricated. PCL also has less chance to induce immunological reaction. Together, it may imply the potential use of PCL as a material-based for GTR membrane.
2. Periodontal tissue healing and regeneration
Like healing processes of the other tissues, periodontal tissue-healing processes are divided into four phases: inflammation, proliferation, matrix formation, and remodelling . First, the stability of blood clot at the defect site is crucial for periodontal tissue regeneration as it supports cell migration and proliferation in the affected area [10, 11]. However, periodontal tissue healing requires a unique healing process due to the complex nature of periodontal apparatus, which composes of cementum, periodontal ligament and alveolar bone. In addition, the distinctive periodontal ligament character requires the formation of collagen fibril embedding on the root surface of the teeth and alveolar bone. This contributes as another unique factor for periodontal tissue healing . It is postulated that connective tissues recognize the exposed root dentin as a foreign body. Therefore, the formation of parallel collagen fibres is noted along the root surface . The exposed root dentin provides a substrate for cementoblast-like cells to attach and differentiate. Further, cementoblasts form extracellular matrix where collagen fibres are anchored .
There are several cell types involved in periodontal regeneration/healing, for example, periodontal fibroblasts, osteoblasts, gingival fibroblasts and epithelial cells. A majority of cells in periodontal tissues is fibroblasts . Fibroblastic cell population contains stem/progenitor cells that can differentiate into fibroblast, osteoblast and cementoblasts, depending on the stimulator [13–15]. These cells further participate in the regeneration and healing of periodontal tissues. However, it has been reported that gingival fibroblasts exhibited significantly higher
3. Guided tissue regeneration
GTR is one of the procedures that could ultimately regenerate the damaged periodontal tissues and restore them to a functional state . GTR procedure is accomplished by placing the GTR membrane over the defect. This membrane acts as a physical barrier separating the gingival tissues and epithelium from the periodontal defect, allowing the required cell population (periodontal ligament cells and osteoblasts) to formulate a new attachment apparatus and functional periodontal tissues (Figure 1) [1, 17–19]. At the same time, the migration of epithelial cells and gingival fibroblasts is prevented. Thus, the formation of long junctional epithelium healing is attenuated .
GTR is well known for its successful clinical uses in an intrabony and furcation defect treatment [1, 18]. A systematic review of literature reports that GTR treatment results in better clinical outcomes than open-flap debridement procedure, for example, the improvement of clinical attachment levels, the reduction of probing depth and gingival recession [4, 20, 21]. Although other benefits of GTR for other types of periodontal defects are not as recognizable, GTR remains a beneficial treatment . In this regard, GTR therapy results in a higher amount of clinical attachment gain than a therapy of accessing flap alone . The disadvantage of GTR is that the result of the treatment varies due to the difference of host response, patient’s oral hygiene, surgical technique and the lack of biological property to facilitate periodontal healing [1, 23–27].
4. Guided tissue regeneration membrane materials
In general, like other biomaterials, GTR membrane should exhibit a biocompatibility. The degradation ability should match with the rate of new tissue formation, and the degradation product should not elicit host-inflammatory response. GTR should have the suitable mechanical and physical properties to maintain its shape
Due to the disadvantage of the non-resorbable membrane, the resorbable membranes are created in order to eliminate the second surgery to remove the membrane . The bioresorbable membranes can be further grouped into two categories: the natural and the synthetic membranes. The advantage of the natural membrane is that these can be degraded by normal physiological or pathological process in vivo . In addition, the natural-derived membranes inherit biological properties that can induce or maintain biological activity of local cells and tissues. Collagen is widely used as a resorbable GTR membrane as it is an abundant structural protein in various types of connective tissues . Although collagen exhibits low immunogenicity, the antigenic response and autoimmunization are noted [29, 31]. Another drawback of collagen is the fast degradation period leading to the failure of GTR treatment due to the downgrowth of epithelial cells, forming long junctional epithelium .
A resorbable membrane made from synthetic materials has the advantage in several aspects. Firstly, the desirable physical and chemical properties can be altered with simple methods . Secondly, fabrication methods are controllable, easy and reproducible. In general, synthetic materials are biocompatible but the degradation products of some synthetic materials induce tissue reaction . Many types of polyester-based material have been clinically utilized as synthetic resorbable membranes . Synthetic materials for GTR membrane include polyglycolic acid (PGA), polylactic acid (PLA), polydioxanone (PDS), and polycaprolactone PGA is an alpha-polyester. PGA is able to hold their mechanical strength for 2–4 weeks after implantation . PLA has higher solubility in organic solvents than PGA because of its molecular structure. PLA has an amorphous poly(d,l-lactide) which is useful for further application in drug delivery. PGA and PLA can be copolymerized to form high-molecular weight copolymers . Periodontal ligament cells attach better on PLA and co-PLA-PGA than on PTFE, and cell proliferation is observed on PLA and co-PLA-PGA but not on PTFE, implying their biocompatibility . PDS is a homopolymer of p-dioxanone. PDS can maintain its strength for 4–8 weeks and completely resorb in 4–6 months . PDS membrane treatment for human infrabony defects demonstrated the reduction of probing depth and the increase of vertical clinical attachment levels as well as bony filling in the defect sites . These results are similar to those defects treated with polylactide acetyltributyl citrate .
5. Bioactive-guided tissue regeneration membrane
With the evolution of tissue-engineering approach, the recent development of GTR membranes is not only used as a physical barrier but also used as a delivery device of specific agents such as antimicrobials, growth factors and stem cells . This development of bioactive GTR membranes aims for facilitating the regeneration and healing of periodontal tissues . This type of membrane is considered as bioactive-guided tissue regeneration membrane. The first approach is to incorporate antimicrobial agents with GTR membrane to attenuate the risk of bacterial infection, leading to the reduction of inflammation process . The bacterial contamination and infection could effect on the healing and regeneration outcome and it has been shown that bacterial infection may be associated with gingival recession and impediment of attachment gain [37, 38]. Local minocycline application in combination with GTR treatment results in the significant higher clinical attachment gain . In addition, GTR loaded with metronidazole reduces inflammatory response in vivo . Further, the antimicrobial-incorporated GTR membrane has been shown to improve the attachment of periodontal ligament cells by effective oral pathogen eradication . The second approach is to incorporate bioactive calcium phosphate in GTR membrane . The addition of hydroxyapatite improves the biocompatibility and osteoconductivity of GTR membrane [42, 43]. These composite membranes also enhance osteoblast cell proliferation
The last approach is to incorporate with growth factor. Growth factors regulate various biological processes, for example, cell differentiation, cell proliferation, angiogenesis and chemotaxis, resulting in the promotion of tissue healing and regeneration. Various growth factors have been identified as factors enhancing periodontal tissue healing. The exemplification of these growth factors is platelet-derived growth factor (PDGF), insulin-like growth factor-1 (IGF-I), fibroblast growth factor-2 (FGF-2), transforming growth factor β-1 (TGFβ-1), bone morphogenetic protein-2 (BMP-2), bone morphogenetic protein-4 (BMP-4), bone morphogenetic protein-7 (BMP-7), bone morphogenetic protein-12 (BMP-12) and enamel matrix derivative (EMD). The example of the development of bioactive GTR membrane is demonstrated in Table 1.
|Human||ePTFE||Tetracycline (3%)||Additional gain of clinical periodontal attachment||Zarkesh et al. |
|Dog||PGA and PLA copolymer||Doxycycline (25%)||More pronounced new bone formation and less crestal bone resorption||Chang and Yamada |
|Human||Collagen||Minocycline||Not significantly beneficial||Minabe et al. |
|Dog||Polytetrafluoroethylene (ePTFF)||Platelet-derived growth factor-BB (PDGF-BB)||Effectively promoted periodontal regeneration||Cho et al. |
|Dog||Polytetrafluoroethylene (ePTFF) (GORE-TFX)||Platelet-derived growth factor-BB (PDGF-BB)||Effectively promoted periodontal regeneration with reproducibility||Park et al. |
|Rat||Poly L-lactide (PLLA)||Platelet-derived growth factor-BB (PDGF-BB)||Enhanced regenerative efficacy||Park et al. |
|Human||Collagen||Trombelli and Farina |
|Dog||Polytetrafluoroethylene (ePTFF) (GORE-TFX)||Recombinant human transforming growth factor-beta1 (rhTGF-β1)||Restricted potential to enhance alveolar bone regeneration in conjunction with guided tissue regeneration||Wikesjö et al. |
|Dog||Collagen||Basic fibroblast growth factor (bFGF)||Enhance periodontal regenerative results, both mineralized and non-mineralized tissues||Rossa et al. |
|Dog||Sandwich membrane: collagen and gelatin||Basic fibroblast growth factor (bFGF)||Active vascularization and osteogenesis|
Successful regeneration of the periodontal tissues in a short period of time
|Nakahara et al. |
|Human||Cellulose||human fibroblast growth factor-2 (FGF-2)||Efficacious in the regeneration of human periodontal tissue||Kitamura et al. |
|Rat||Alginate/nanofibre||Recombinant bone morphogenetic protein-2 (rhBMP-2)||Effective in repair of critical-sized segmental defect||Kolambkar et al. |
6. Polycaprolactone in guided tissue regeneration
PCL is a semi-crystalline, aliphatic polyester . The structure of PCL comprises a repeating unit of one ester group and five methylene groups (Figure 2). PCL has an excellent biocompatibility and slow degradation rate [7, 58]. In regard to many studies, there is no evidence revealing that PCL could potentially induce any cytotoxic effects nor accumulate in human body . Its ester linkages can be hydrolysed and excreted under normal physiological conditions. The degradation rate of PCL is slower than other aliphatic polyester . In this regard, the degradation of PCL and its copolymers can be altered with different form and molecular weight of the materials. The high-molecular-weight (≥50,000 g/mol) PCL requires 3 years to degrade in host .
Therefore, PCL is a practicable option for many applications in tissue-engineering approaches. PCL been approved by the Food and Drug Administration (FDA) for several medical applications, for example, suture materials and subdermal contraceptive implants [57, 61, 62]. It has been applied as a beneficial biomaterial for drug delivery devices [63, 64]. The drug-releasing property is able to be controlled . Thus, the biological activity could be lengthened . For example, PCL was employed as wound-dressing materials, which released chemical antiseptic agent . In dentistry, PCL has been introduced as root canal-filling materials. It was noted that PCL-filled root canal gave a predictable seal in an aqueous environment . PCL is also employed as materials for bone tissue-engineering scaffolds that could be used for bone augmentation [58, 67–69]. Furthermore, PCL composites are recognized for its significant uses in tissue-engineering scaffolds in order to regenerate bone, ligament, cartilage, skin, nerve and vascular tissues . PCL-based biomaterials have demonstrated the osteoconductive properties as they support various cell proliferations and differentiations, including bone marrow-derived mesenchymal stem cells (BMSCs), dental pulp stem cells (DPSCs) and adipose-derived mesenchymal stem cells (ADSCs) in PCL scaffold which was confirmed [68, 69]. Further, PCL implantation in murine calvarial defect model does not significantly increase the total IgG levels as compared with sham surgery group, demonstrating the immune compatibility of PCL-based materials .
As aforementioned, there has been a development in manufactured membrane used for GTR in order to meet its basic requirements. PCL is considered as satisfactory candidate for GTR due to its useful properties such as biocompatibility, proper mechanical strength, biodegradability and ease of fabrication [71–73]. Many studies investigated on the effectiveness of PCL membrane in GTR reveals an improvement of bone formation in the presence of noticeable bone cell attachment and proliferation [74, 75]. PCL and hydroxyapatite-incorporated PCL membrane were biocompatible and able to support human periodontal ligament cell attachment, spreading and proliferation (Figure 3). It was also shown that nano-apatite-incorporated PCL membrane facilitates osteoblast-like cell proliferation and differentiation . Moreover, hydroxyapatite and gelatin nanocomposite-incorporated PCL supported osteoblast proliferation, induced alkaline phosphatase activity and enhanced mineralization . For further study, the researcher has invented a new polymer/calcium phosphate composite for guided tissue regeneration use. Osteoblast alkaline phosphatase activity and expression of osteoblast marker gene, which indicates the promotion in bone maturation, have been recorded as the result . The basic fibroblast growth factor-releasing heparin-conjugated PCL membrane has been successfully developed and exhibits biocompatibility. This basic fibroblast growth factor-releasing PCL membrane promotes human osteoblast-like cell attachment, proliferation and differentiation as compared with the naïve PCL membrane . Metronidazole-incorporated PCL-based membranes decrease inflammatory response, determined in subcutaneous implantation model as compared to the unmodified PCL membrane [40, 80]. According to these studies, PCL become an appropriate material for the use of GTR membrane and advantageous prototype for further clinical membrane invention .
Beside GTR membrane, PCL has been developed as bone-defect-filling materials aiming to promote bone regeneration in periodontal defects. The scaffolds aim to support periodontal ligament and alveolar bone cell migration and repopulation in the affected site, facilitating the regeneration process. Three-dimensional PCL scaffolds can be fabricated by a modified solvent casting and particulate-leaching techniques, resulting in the highly porous and interconnected structure in PCL scaffolds . Hydroxyapatite incorporation in PCL scaffolds exhibited biocompatibility and degradability . These scaffolds have osteoconductive property which enhanced primary human osteoblast response
7. Notch signalling as a potential bioactive molecule in guided tissue regeneration of periodontal tissues
Notch ligands, Jagged1, promote cell differentiation towards osteoblast lineages of human periodontal ligament stem cells and bone marrow-derived mesenchymal stem cells [83–85]. Other studies also demonstrated that Jagged1-immobilized surface could reduce epithelial cell proliferation and enhanced epithelial cell differentiation [86, 87]. In addition, in rafted organ culture model, Jagged1-coated porous biomaterial significantly reduced the formation of epithelial tongue . In other words, Jagged1 could prevent epithelial cells migration down into the dermis. For this reason, Jagged1 is considered as a beneficial molecule to be coated on a guided tissue regeneration membrane to enhance periodontal tissue formation. The schematic diagram of the propose idea is demonstrated in Figure 4. The Jagged1-coated PCL membrane firstly acts as a physical barrier to prevent epithelial down-growth into periodontal-defect site. In biological events, Jagged1 inhibits proliferation and induced the differentiation of epithelial cells. Further, Jagged1 promoted osteogenic differentiation of periodontal ligament cells and alveolar osteoblast cells. Together, these effects prevent the epithelium downgrowth in the lesion and promote the formation of alveolar bone, leading to the achievement of successful guided tissue regeneration.
The present chapter reviews the biological basis of GTR membrane in periodontal tissue healing and regeneration. In the past, GTR acts as a physical barrier to allow required cells to facilitate periodontal tissue formation. Recently, bioactive GTR membrane has been investigated and developed aiming to fabricate membrane that not only act as a physical barrier but also induce biological events to enhance periodontal tissue regeneration. PCL has been introduced as candidate materials for bioactive GTR membrane due to its biocompatibility and simple fabrication procedure. The modification with other agents/biomolecules could be easily constructed. With the use of proposed Notch ligands, PCL-decorated Jagged1 could be beneficial to promote periodontal tissue formation. However, further investigations are indeed required.
The authors are supported by the Faculty of Dentistry Research Fund, Chulalongkorn University.